Comment diagnostiquer une dépendance aux benzodiazépines ?

Le diagnostic repose sur l'évaluation des symptômes et l'historique d'utilisation des médicaments.

Quels tests sont utilisés pour évaluer l'usage des benzodiazépines ?

Des tests de dépistage de drogues et des évaluations psychologiques peuvent être utilisés.

Quels critères DSM sont utilisés pour le diagnostic ?

Les critères DSM-5 incluent l'usage excessif et les symptômes de sevrage.

Comment évaluer l'efficacité d'un traitement par benzodiazépines ?

L'efficacité est évaluée par la réduction des symptômes d'anxiété ou d'insomnie.

Quels signes indiquent une surdose de benzodiazépines ?

Les signes incluent confusion, somnolence excessive et difficultés respiratoires.

Quels sont les effets secondaires courants des benzodiazépines ?

Les effets secondaires incluent somnolence, vertiges et troubles de la mémoire.

Comment reconnaître une réaction allergique aux benzodiazépines ?

Les réactions allergiques peuvent se manifester par éruptions cutanées et démangeaisons.

Quels symptômes indiquent un sevrage des benzodiazépines ?

Les symptômes de sevrage incluent anxiété, insomnie et tremblements.

Les benzodiazépines provoquent-elles des troubles cognitifs ?

Oui, elles peuvent entraîner des troubles de la mémoire et de la concentration.

Quels symptômes peuvent nécessiter une consultation médicale urgente ?

Des symptômes comme confusion sévère ou difficultés respiratoires nécessitent une urgence.

Comment prévenir la dépendance aux benzodiazépines ?

La prévention inclut une prescription prudente et une éducation sur les risques.

Quels conseils donner aux patients sur l'utilisation des benzodiazépines ?

Les patients doivent être informés des risques et de l'importance de suivre les prescriptions.

Comment surveiller l'utilisation des benzodiazépines ?

Les médecins doivent effectuer des suivis réguliers pour évaluer l'usage et les effets.

Quelles stratégies non médicamenteuses peuvent aider ?

Des techniques comme la méditation et l'exercice physique peuvent réduire l'anxiété.

Comment sensibiliser sur les risques des benzodiazépines ?

Des campagnes d'information et des ateliers peuvent sensibiliser le public aux risques.

Comment traiter une dépendance aux benzodiazépines ?

Le traitement inclut une désintoxication supervisée et une thérapie comportementale.

Quelles alternatives existent aux benzodiazépines pour l'anxiété ?

Les alternatives incluent les antidépresseurs et les thérapies cognitivo-comportementales.

Comment réduire progressivement l'utilisation des benzodiazépines ?

La réduction doit être progressive, sous supervision médicale pour éviter le sevrage.

Quels médicaments peuvent aider à gérer le sevrage ?

Des médicaments comme le diazépam peuvent être utilisés pour atténuer les symptômes de sevrage.

Quelle est la durée recommandée pour l'utilisation des benzodiazépines ?

L'utilisation est généralement recommandée pour une courte durée, souvent moins de 4 semaines.

Quelles complications peuvent survenir avec l'usage prolongé ?

L'usage prolongé peut entraîner des troubles cognitifs et une dépendance sévère.

Comment les benzodiazépines affectent-elles la santé mentale ?

Elles peuvent aggraver des troubles mentaux comme la dépression et l'anxiété.

Quels risques sont associés à l'association avec d'autres médicaments ?

L'association avec des opioïdes ou l'alcool augmente le risque de dépression respiratoire.

Les benzodiazépines peuvent-elles provoquer des chutes chez les personnes âgées ?

Oui, elles augmentent le risque de chutes et de fractures chez les personnes âgées.

Quels effets à long terme sur la mémoire sont observés ?

L'usage prolongé peut entraîner des troubles de la mémoire et des difficultés d'apprentissage.

Quels facteurs augmentent le risque de dépendance ?

Les antécédents de troubles mentaux et l'usage prolongé augmentent le risque de dépendance.

Comment l'âge influence-t-il l'usage des benzodiazépines ?

Les personnes âgées sont plus susceptibles de subir des effets secondaires et des complications.

Quel rôle joue l'environnement social dans l'usage ?

Un environnement stressant ou un manque de soutien social peut augmenter l'usage des benzodiazépines.

Les antécédents familiaux influencent-ils l'usage ?

Oui, des antécédents familiaux de dépendance peuvent augmenter le risque d'usage problématique.

Comment les troubles de santé mentale affectent-ils l'usage ?

Les personnes avec des troubles de santé mentale sont plus susceptibles d'utiliser des benzodiazépines.

Benzodiazépines - Informations médicales vérifiées

Induction of labour at or near term for suspected fetal macrosomia.

08 03 2023

DOI: 10.1002/14651858.CD000938.pub3 PMID: 36884238

Women with a suspected large-for-dates fetus or a fetus with suspected macrosomia (birthweight greater than 4000 g) are at risk of operative birth or caesarean section. The baby is also at increased r... To assess the effects of a policy of labour induction at or shortly before term (37 to 40 weeks) for suspected fetal macrosomia on the way of giving birth and maternal or perinatal morbidity.... We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2016), contacted trial authors and searched reference lists of retrieved studies.... Randomised trials of induction of labour for suspected fetal macrosomia.... Review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We contacted study authors for additional information. For key outcomes the q... We included four trials, involving 1190 women. It was not possible to blind women and staff to the intervention, but for other 'Risk of bias' domains these studies were assessed as being at low or unc... Induction of labour for suspected fetal macrosomia has not been shown to alter the risk of brachial plexus injury, but the power of the included studies to show a difference for such a rare event is l...

Infant Infant, Newborn Pregnancy Female Humans +6 autres

Dietary Regulation of Lipid Metabolism in Gestational Diabetes Mellitus: Implications for Fetal Macrosomia.

19 Oct 2024

DOI: 10.3390/ijms252011248 PMID: 39457029

The primary therapeutic approach for managing hyperglycemia today is diet therapy. Lipids are not only a source of nutrients but also play a role in initiating adipocyte differentiation in the fetus, ...

Humans Diabetes, Gestational Pregnancy Female Fetal Macrosomia +5 autres

Association between maternal factors and fetal macrosomia in full-term singleton births.

01 03 2023

DOI: 10.1097/JCMA.0000000000000871 PMID: 36728402

Macrosomia, defined as a birth weight of ≥4000 g, is associated with a high risk of birth injury. Fetal growth is highly correlated with maternal conditions, and several maternal factors are associate... The medical records of pregnant mothers and their newborns were retrospectively reviewed. All singleton pregnancies delivered at and after 37 weeks of gestation were included in the analysis. Maternal... A total of 4262 infants were enrolled in our study. The mean birth weight was 3156 ± 383 g, including 77 (1.8%) cases with birth weight ≥4000 g, and 154 (3.6%) infants with birth weight <2500 g. The m... Gestational diabetes mellitus, 6mGWG, and maternal BMI are significantly correlated with neonatal macrosomia in full-term singleton births. Further, neonatal macrosomia is an important cause of matern...

Infant Female Infant, Newborn Pregnancy Humans +7 autres

Effect of anesthesia type on outcome measures in cesarean section in the presence of fetal macrosomia.

2022

DOI: 10.1590/1806-9282.20220382 PMID: 36417645

The aim of this study was to compare the effects of general and spinal anesthesia on maternal and neonatal outcomes during cesarean section in pregnancies with macrosomia.... This retrospective cohort study included 1043 patients who delivered by cesarean section between May 2018 and December 2021 and had a baby born with a birth weight of 4000 g or greater. Maternal and n... Neonates with an Apgar score of <7 at the first minute (11.4 vs. 0.4%; p<0.001) and the fifth minute (2.9 vs. 0.3%; p=0.004) were significantly higher in the general anesthesia group. The preoperative... Apgar scores of <7 at the first and fifth minutes are higher in macrosomic neonates who received general anesthesia than in neonates who received spinal anesthesia. Performing cesarean section under g...

Infant, Newborn Humans Pregnancy Female Cesarean Section +5 autres

Impact of induction of labor in fetal macrosomia: comparative series from 256 cases.

10 2022

DOI: 10.1007/s00404-022-06685-z PMID: 35852647

The management of fetal macrosomia remains controversial. A protocol for induction of labor in the case of a suspected macrosomic fetus has been in place in our maternity hospital since 2016. We studi... Retrospective, comparative, single-center study including 256 patients between 2016 and 2020 in a type 3 maternity hospital in France. We compared 114 patients induced at 39 weeks of gestation (fetal ... The rate of vaginal delivery in the group 1 was 78.9% vs 83.8% in group 2 (p = 0.318). The rate of neonatal acidosis in group 1 was statistically lower than in group 2 (5.2% vs 16.9%; p = 0.004). The ... The establishment of a protocol for the induction of labor in the case of macrosomia in our maternity hospital did not increase the rate of vaginal delivery, but has a neonatal benefit, by significant...

Delivery, Obstetric Female Fetal Macrosomia Humans Infant, Newborn +4 autres

Non-diabetic fetal macrosomia: outcomes of elective delivery versus expectant management.

Jun 2023

DOI: 10.1007/s11845-022-03076-w PMID: 35781860

Macrosomia in the absence of diabetes can be associated with increased neonatal and maternal morbidity. Management is usually undertaken on a case-by-case basis.... In order to inform local practice, this study aimed to evaluate the outcomes of the management of non-diabetic macrosomia in an Irish tertiary center.... A retrospective observational study was performed on all women with estimated fetal weight over 4000 g after 37 weeks' gestation. Maternal demographics and obstetric and neonatal outcomes were recorde... Overall, there was no difference in major maternal or neonatal outcomes between management options for fetal macrosomia. However, inducing nulliparas with an unfavorable cervix for non-diabetic macros...

Infant, Newborn Pregnancy Female Humans Cesarean Section +4 autres

Umbilical Cord Biometry and Fetal Abdominal Skinfold Assessment as Potential Biomarkers for Fetal Macrosomia in a Gestational Diabetes Romanian Cohort.

26 Aug 2022

DOI: 10.3390/medicina58091162 PMID: 36143839

Backgroundand Objectives: Gestational diabetes mellitus (GDM) is a pregnancy-associated pathology commonly resulting in macrosomic fetuses, a known culprit of obstetric complications. We aimed to eval...

Biomarkers Biometry Case-Control Studies Diabetes, Gestational Female +6 autres

Fetal macrosomia, fetal insulin, and insulin-like growth factor- 1 among neonates in Lagos, Nigeria: A case-control study.

2022

DOI: 10.1371/journal.pone.0266314 PMID: 36001625

Fetal macrosomia is associated with perinatal injuries. The purpose of this study was to assess the relationship between fetal insulin, insulin-like Growth factor-1(IGF-1), and macrosomia in a resourc... This was a case-control study at tertiary and secondary health facilities in Lagos, Nigeria. One hundred and fifty mother-neonate pairs were recruited, and their socio-demographic and obstetric histor... Macrosomic neonates had mean fetal weight, fetal length, and occipitofrontal circumference (OFC) of 4.15±0.26kg, 50.85±2.09cm and 36.35± 1.22cm respectively. The median Insulin (P = 0.023) and IGF-1 (... Among participating mother-neonate dyad, maternal BMI at birth, neonate's gender, and fetal cord serum IGF-1 and serum insulin are significantly associated with fetal macrosomia....

Birth Weight Case-Control Studies Female Fetal Blood Fetal Macrosomia +9 autres

Fasting plasma glucose and fetal ultrasound predict the occurrence of neonatal macrosomia in gestational diabetes mellitus.

19 Apr 2023

DOI: 10.1186/s12884-023-05594-6 PMID: 37076807

The cause of fetal overgrowth during pregnancy is still unclear. This study aimed to analyze and predict the risk of macrosomia in pregnant women with gestational diabetes mellitus (GDM).... This study was a retrospective study collected from October 2020 to October 2021. A total of 6072 pregnant women with a routine 75-g oral glucose tolerance test (OGTT) during 24-28 gestational weeks w... The data of perinatal outcomes of 322 GDM and 353 NGT who had given birth to single live babies at term were analyzed. We found that significant cut-off values for the prediction of macrosomia are 5.1... FPG is positively associated with newborn birth weight. An early intervention to prevent macrosomia may be possible by combining maternal GWG, FPG, FWG, and AFI in gestational diabetes....

Infant, Newborn Pregnancy Female Humans Diabetes, Gestational +7 autres

Determinants of fetal macrosomia among live births in southern Ethiopia: a matched case-control study.

02 Jun 2022

DOI: 10.1186/s12884-022-04734-8 PMID: 35655197

Fetal macrosomia defined as birth weight of 4000 g and above regardless of gestational age and associated with adverse maternal and fetal outcomes, especially among women in developing countries like ... A facility-based matched case-control study design involved 360 singletons deliveries attended at hospitals in Wolaita Sodo town, southern Ethiopia, with 120 cases and 240 controls included. Cases and... Male neonates were four times more likely to be macrosomia than female neonates MAOR = 4.0 [95%CI; 2.25-7.11, p < 0.001]. Neonates born at gestational age ≥ 40 weeks were 4.33 times more likely to be ... Mothers' physical exercise and consumption of fruit and dairy products were significant predictor variables for fetal macrosomia. Hence, health care providers may use these factors as a screening tool...

Birth Weight Case-Control Studies Ethiopia Female Fetal Macrosomia +8 autres

Benzodiazépines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Alprazolam

Benzodiazépinones

Chlordiazépoxyde

Clobazam

Clorazépate dipotassique

Estazolam

Médazépam

Midazolam

Olanzapine

Triazolam

Bromazépam

Clonazépam

Dévazépide

Diazépam

Flumazénil

Flunitrazépam

Flurazépam

Lorazépam

Nitrazépam

Oxazépam

Pirenzépine

Prazépam

Témazépam

Nordazépam

Auteurs principaux

Sources (5024 au total)